358 related articles for article (PubMed ID: 16441623)
1. What defines the quality of patient care in tinea pedis?
Mistik S; Ferahbas A; Koc AN; Ayangil D; Ozturk A
J Eur Acad Dermatol Venereol; 2006 Feb; 20(2):158-65. PubMed ID: 16441623
[TBL] [Abstract][Full Text] [Related]
2. In vitro activities of four antifungal drugs against Trichophyton rubrum isolates exhibiting resistance to fluconazole.
Santos DA; Hamdan JS
Mycoses; 2007 Jul; 50(4):286-9. PubMed ID: 17576321
[TBL] [Abstract][Full Text] [Related]
3. In vitro antifungal susceptibility patterns of dermatophyte strains causing tinea unguium.
Sarifakioglu E; Seçkin D; Demirbilek M; Can F
Clin Exp Dermatol; 2007 Nov; 32(6):675-9. PubMed ID: 17714532
[TBL] [Abstract][Full Text] [Related]
4. Oxiconazole nitrate: pharmacology, efficacy, and safety of a new imidazole antifungal agent.
Jegasothy BV; Pakes GE
Clin Ther; 1991; 13(1):126-41. PubMed ID: 2029718
[TBL] [Abstract][Full Text] [Related]
5. Effectiveness and tolerability of a standardized extract from Ageratina pichinchensis on patients with tinea pedis: an explorative pilot study controlled with ketoconazole.
Romero-Cerecero O; Rojas G; Navarro V; Herrera-Arellano A; Zamilpa-Alvarez A; Tortoriello J
Planta Med; 2006 Nov; 72(14):1257-61. PubMed ID: 17051456
[TBL] [Abstract][Full Text] [Related]
6. In vitro antifungal activity of KP-103, a novel triazole derivative, and its therapeutic efficacy against experimental plantar tinea pedis and cutaneous candidiasis in guinea pigs.
Tatsumi Y; Yokoo M; Arika T; Yamaguchi H
Antimicrob Agents Chemother; 2001 May; 45(5):1493-9. PubMed ID: 11302816
[TBL] [Abstract][Full Text] [Related]
7. Antifungal susceptibilities of dermatophytic agents isolated from clinical specimens.
Cetinkaya Z; Kiraz N; Karaca S; Kulac M; Ciftci IH; Aktepe OC; Altindis M; Kiyildi N; Piyade M
Eur J Dermatol; 2005; 15(4):258-61. PubMed ID: 16048753
[TBL] [Abstract][Full Text] [Related]
8. Experimental and clinical investigation on oxiconazole.
Wu SX; Shen YN; Yan N; Guo NR; Liu LL; Yang JQ
Chin Med J (Engl); 1989 Aug; 102(8):644-6. PubMed ID: 2517622
[TBL] [Abstract][Full Text] [Related]
9. In vitro susceptibility testing of dermatophytes: comparison of disk diffusion and reference broth dilution methods.
Karaca N; Koç AN
Diagn Microbiol Infect Dis; 2004 Apr; 48(4):259-64. PubMed ID: 15062918
[TBL] [Abstract][Full Text] [Related]
10. Ciclopirox olamine lotion 1%: bioequivalence to ciclopirox olamine cream 1% and clinical efficacy in tinea pedis.
Aly R; Maibach HI; Bagatell FK; Dittmar W; Hänel H; Falanga V; Leyden JJ; Roth HL; Stoughton RB; Willis I
Clin Ther; 1989; 11(3):290-303. PubMed ID: 2663159
[TBL] [Abstract][Full Text] [Related]
11. Comparison of in vitro activities of antifungal drugs and ethanolic extract of propolis against Trichophyton rubrum and T. mentagrophytes by using a microdilution assay.
Koc AN; Silici S; Ayangil D; Ferahbaş A; Cankaya S
Mycoses; 2005 May; 48(3):205-10. PubMed ID: 15842339
[TBL] [Abstract][Full Text] [Related]
12. [Econazole nitrate. In vitro tests and clinical trial].
Dorn M; Scherwitz C; Lentze I; Plewig G
MMW Munch Med Wochenschr; 1975 Apr; 117(16):687-92. PubMed ID: 805931
[TBL] [Abstract][Full Text] [Related]
13. Comparison of in vitro antifungal activity of novel triazoles with available antifungal agents against dermatophyte species caused tinea pedis.
Salehi Z; Fatahi N; Taran M; Izadi A; Badali H; Hashemi SJ; Rezaie S; Daie Ghazvini R; Ghaffari M; Aala F; Barac A; Khodavaisy S
J Mycol Med; 2020 Jun; 30(2):100935. PubMed ID: 32139093
[TBL] [Abstract][Full Text] [Related]
14. Mycological and electron microscopic study of Solanum chrysotrichum saponin SC-2 antifungal activity on Candida species of medical significance.
Herrera-Arellano A; Martínez-Rivera Mde L; Hernández-Cruz M; López-Villegas EO; Rodríguez-Tovar AV; Alvarez L; Marquina-Bahena S; Navarro-García VM; Tortoriello J
Planta Med; 2007 Dec; 73(15):1568-73. PubMed ID: 18058612
[TBL] [Abstract][Full Text] [Related]
15. In vitro evaluation of griseofulvin, ketoconazole, and itraconazole against various dermatophytes in Singapore.
Goh CL; Tay YK; Ali KB; Koh MT; Seow CS
Int J Dermatol; 1994 Oct; 33(10):733-7. PubMed ID: 8002147
[TBL] [Abstract][Full Text] [Related]
16. Determination of susceptibility/resistance to antifungal drugs of Trichophyton mentagrophytes isolates by a macrodilution method.
Barros ME; Hamdan JS
Can J Microbiol; 2005 Nov; 51(11):983-7. PubMed ID: 16333338
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetic investigation of oral itraconazole in stratum corneum level of tinea pedis.
Morimoto K; Tanuma H; Kikuchi I; Kusunoki T; Kawana S
Mycoses; 2004 Apr; 47(3-4):104-14. PubMed ID: 15078426
[TBL] [Abstract][Full Text] [Related]
18. In vitro susceptibility testing of amorolfine in pathogenic fungi isolated from dermatomycosis patients in China.
Li RY; Wan Z; Wang AP; Shen YN; Lu CM; Li M; Xi LY; Liu WD; Zeng FQ
Mycoses; 2004 Oct; 47(9-10):402-6. PubMed ID: 15504124
[TBL] [Abstract][Full Text] [Related]
19. Blad-containing oligomer: a novel fungicide used in crop protection as an alternative treatment for tinea pedis and tinea versicolor.
Carreira A; Ferreira JB; Pereira I; Ferreira J; Filipe P; Ferreira RB; Monteiro S
J Med Microbiol; 2018 Feb; 67(2):198-207. PubMed ID: 29388537
[TBL] [Abstract][Full Text] [Related]
20. Double-blind study of the efficacy of 1 week topical terbinafine cream compared to 4 weeks miconazole cream in patients with tinea pedis.
Leenutaphong V; Niumpradit N; Tangwiwat S; Sritaveesuwan R; Muanprasat C
J Med Assoc Thai; 1999 Oct; 82(10):1006-10. PubMed ID: 10561963
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]